Life sciences sector explored at Cork event
“Cork represents a convergence of talent and academic excellence, and we look forward to deepening our relationships across Munster’s educational institutions and life sciences ecosystem.”
Those were the words of Sylvia Kiely, VP, Global Supply Chain and Product Strategy Lead, Alexion and AstraZeneca Rare Disease during a recent event on Leeside.
She added: “By working together, we nurture future talent and build on the region’s strengths through ongoing collaboration and shared purpose.”
Her comments came as Alexion and AstraZeneca Rare Disease welcomed government officials, academic leaders, and industry partners to its hub in Cork, reinforcing the company's commitment to productive partnerships and collaborative relationships within Ireland's life sciences sector.
Alongside established global operations in Dublin and Athlone, those at the event heard how the Cork hub demonstrates Alexion’s dedication to building enduring connections across Ireland.
Cork serves as a base for senior technical roles in manufacturing, supply chain, quality, and technical operations.
Shane Doyle, Senior Vice President, Global Operations and Sustainability, Alexion, AstraZeneca Rare Disease, said: “Ireland has long stood as a cornerstone of our global network, and our partnerships here reflect both our confidence in the country's talent, infrastructure, and supportive business environment, and our shared commitment to collaboration. Working closely within the Irish life sciences community allows us to enhance specialist capabilities in supply chain and technical operations, ultimately delivering our life-changing medicines to more patients around the world.”
Across Dublin, Athlone, and Cork, Alexion and AstraZeneca employ approximately 1,400 people in development, manufacturing, supply, and commercial roles, working together with colleagues, partners, and educational experts to advance solutions for rare disease patients.
Michael Lohan, CEO of IDA Ireland, said: “I would like to congratulate Alexion, AstraZeneca Rare Disease on establishing its operations hub in Cork. Their presence here underscores Ireland and indeed Cork’s reputation as a key hub for the life sciences sector. With its well-established talent base, robust infrastructure, and pro-business environment, Ireland continues to attract strategic investments from world-leading companies. I would like to wish Alexion every success in the coming years.”